Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.
More than 150 patient cases teach you how to apply the principles of pharmacotherapy to real-world clinical practice
The essential study companion to DiPiro’s Pharmacotherapy: A Pathophysiologic Approach, 10th Edition
Pharmacotherapy Casebook: A Patient-Focused Approach uses 157 patient cases to help you develop the skills necessary to identify and resolve the most common drug therapy problems encountered in daily clinical practice. The case chapters are organized into organ system sections that correspond to those of the companion textbook. This proven effective case-based approach makes the book perfect for PharmD, Nursing, Nurse Practitioner, and other allied health courses
Sharpen your ability to:
•Identify actual or potential drug therapy problems
•Determine the desired therapeutic outcome
•Evaluate therapeutic alternatives
•Design an optimal individualized pharmacotherapeutic plan
•Develop methods to evaluate the therapeutic outcome
•Provide patient education
•Communicate and the implement the pharmacotherapeutic plan
Develop expertise in pharmacotherapy decision making with:
•Realistic patient presentations that include medical history, physical examination, and laboratory data, followed by a series of questions using a systematic, problem-solving approach
•A compelling range of cases – from a single disease state to multiple disease states and drug-related problems
•Expert coverage that integrates the biomedical and pharmaceutical sciences with therapeutics
•Appendices containing valuable information on medical abbreviations, laboratory tests, mathematical conversion factors, and anthropometrics

Pharmacotherapy Casebook: A Patient-Focused Approach, Tenth Edition

Medical Books

Koehler, Julia

Borchert, Jill

Slain, Douglas

Park, Sharon

Schwinghammer,Terry

Pharmacology

McGraw-Hill Medical

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.
Make the right drug therapy decisions with the definitive guide to pharmacotherapy principles applied in everyday practice
Sub Head: Study companion to DiPiro’s Pharmacotherapy: A Pathophysiologic Approach, 11th Edition
Packed with 157 patient cases, Pharmacotherapy Casebook: A Patient-Focused Approach builds your problem-solving and decision-making skills, so you can identify and resolve the most common drug therapy challenges you’ll encounter in daily practice. Its case-based approach is also ideal for PharmD, Nurse Practitioner, and other allied health courses. Providing a consistent, practical approach, this authoritative guide delivers everything you need to master patient communication, care plan development, and documenting interventions. Case chapters are organized into system sections that correspond to those of the companion textbook. 
Sharpen your ability to:
<ul>• Identify actual or potential drug therapy problems • Determine the desired therapeutic outcome • Evaluate therapeutic alternatives • Design an optimal individualized pharmacotherapeutic plan • Evaluate the therapeutic outcome • Provide patient education • Communicate and implement the therapeutic planDevelop expertise in pharmacotherapy decision making with:
• Realistic patient presentations that include medial history, physical examination, and laboratory data, followed by a series of questions using a systematic, problem-solving approach • A broad range of cases―from a single disease state to multiple disease states and drug-related problems • Expert coverage that integrates the biomedical and pharmaceutical sciences with therapeutics • Appendices containing sample answer to several cases and valuable information on medical abbreviations, laboratory tests, mathematical conversion factors, and anthropometrics 
</ul>

Pharmacotherapy Casebook: A Patient-Focused Approach, Eleventh Edition

Schwinghammer, Terry L.

Koehler, Julia M.

Borchert, Jill S.

Park, Sharon K.

Make the right drug therapy decisions with the leading guide to applying pharmacotherapy principles to real-world clinical practice 
The perfect companion to DiPiro's Pharmacotherapy: A Pathophysiologic Approach, 12th Edition 
Pharmacotherapy Casebook: A Patient-Focused Approach uses 150+ cases to help you build the clinical decision-making skills required to identify and resolve commonly encountered medication therapy problems encountered in daily practice. Providing a consistent, practical approach, this authoritative guide delivers everything you need to master patient communication, care plan development, and documenting interventions. Case chapters are organized into system sections that correspond to those of the companion textbook. The case-based approach makes this an ideal resource for PharmD, Nurse Practitioner, and other allied health courses. 
With each case you will learn how to: Identify actual or potential drug therapy problems Determine the desired therapeutic outcome Evaluate therapeutic alternatives Design an optimal individualized pharmacotherapeutic plan Develop methods to evaluate the therapeutic outcome Provide patient education Communicate and implement the pharmacotherapeutic plan 
Everything you need to develop expertise in pharmacotherapy decision-making: 
Realistic patient presentations include medical history, physical examination, and laboratory data, followed by a series of questions using a systemic, problem-solving approach Compelling range of cases―from the uncomplicated (a single disease state) to the complex (multiple disease states and drug-related problems) Coverage that integrates the biomedical and pharmaceutical sciences with therapeutics Appendices containing valuable information on pharmacy abbreviations, laboratory tests, mathematical conversion factors, anthropometrics, and complementary and alternative therapies Content that is ideal for both pharmacy and nurse practitioner markets

Schwinghammer's Pharmacotherapy Casebook: A Patient-Focused Approach, Twelfth Edition

The new Rule 506 changes everything. The SEC has lifted an 80-year ban on general solicitation. Start-ups for the first time can use public advertising to sell private offerings. The new Rule 506 may prove to be the answer to the prayers of star-ups frustrated with existing fund sourcing platforms. But it also has hidden dangers that will cause many issuers to continue to use the “old Rule 506” [506(b)]. Among the new Rule 506 strengths: • The amount that can be raised is unlimited • There is no requirement for review of the offering under any Blue Sky laws (state securities regulations) • There is no review of the offering by the SEC • Solicitations can be online or offline • Solicitations can be made to anyone! Sales (as opposed to solicitations) must be to accredited investors, and issuers must be able to verify that any actual investor is “accredited.” Also, proposed rules will require issuers to send the SEC all marketing copy; as of this writing, however, there is no need to send copies of solicitation materials to the SEC (or to state regulators). Soon you will start to see: • Emails asking if you might be interested in learning about investing in someone’s project • Videos of founders and entrepreneurs soliciting your interest in their projects • Links on websites inviting you to click through to learn more about an investment • Mobile apps with increasingly creative solicitation

Crowdfunding on Steroids: General Solicitation under Rule 506(c) (Private Placement Handbook Series)

Business & Money

Economics

CreateSpace Independent Publishing Platform

Business Brokers and Securities Laws is a monograph on securities law and finders fees.

Business Brokers and Securities Laws: How to Avoid Becoming an Unlicensed Broker-Dealer (Private Placement Handbook Series)

Business Development & Entrepreneurship

The new Rule 506 changes everything. The SEC has lifted an 80-year ban on general solicitation and start-ups and other Issuers for the first time can use public advertising to sell private offerings. The new Rule 506 may prove to be the answer to the prayers of startups frustrated with existing fund sourcing platforms. But it also has hidden dangers that will cause many issuers to continue to use the “old Rule 506” [506(b)]. Among the new Rule 506 strengths: • The amount that can be raised is unlimited • There is no requirement for review of the offering under any Blue Sky laws (state securities regulations) • There is no review of the offering by the SEC • Solicitations can be online or offline • Solicitations can be made to anyone! Sales (as opposed to solicitations) must be to accredited investors, and issuers must be able to verify that any actual investor is “accredited.” Also, proposed rules will require issuers to send the SEC all marketing copy; as of this writing, however, there is no need to send copies of solicitation materials to the SEC (or to state regulators). Soon you will start to see: • Emails asking if you might be interested in learning about investing in someone’s project • Videos of founders and entrepreneurs soliciting your interest in their projects • Links on websites inviting you to click through to learn more about an investment • Mobile apps with increasingly creative solicitation Investment funds now will have access to a much wider pool of potential investors than before, subject to separate rules and regulations promulgated by their own, separate regulators.

Securitized Real Estate and 1031 Exchanges (Private Placement Series)

See the best price to sell, buy, or rent books by Slain, Douglas. BookScouter helps to compare book prices from 25+ online bookstores and 30+ buyback vendors with a single search.

Books by Slain, Douglas